Akeso Biomedical has received a US patent covering some of its work to reduce the presence of the bacterium campylobacter in poultry using an antibiotic-free feed additive, says COO.
Patent No. US 9,655,912 B2 titled “Reduction of Gastrointestinal Tract Colonization by Campylobacter”
Funding for the Commercial Launch of Feed Additives for Poultry and Piglets to Combat Foodborne Illnesses and Improve Animal Microbiomes
By Joseph Harvey, Animal Pharm News
A US start-up is launching its debut feed additive product designed to reduce the effect of harmful bacteria in the EU ahead of the US, as the US lags behind Europe in understanding and controlling campylobacter, says COO.
Significant reductions of enteropathogens in the GI tracts of broilers – by up to 3 log CFUs/gram in caeca
Hedge fund manager to bring extensive financial expertise to the board.
Former president of Tyson Foods International to help commercialize food safety technology.
Akeso Biomedical is number four on list.
New class of feed additives promises unique solution to Campylobacter.
New class of compounds promises solution to Campylobacter food poisoning.
M.I.T. biotechnology professor to help expand Company’s technical portfolio and seek new solutions for treatment of bacterial infections and biofilms.